Severe Acute Respiratory Syndrome

Clin Infect Dis. 2004 May 15;38(10):1420-7. doi: 10.1086/420743. Epub 2004 Apr 29.

Abstract

The first cases of severe acute respiratory syndrome (SARS) occurred in China in November 2002. The agent causing this illness has been identified as a novel coronavirus, SARS-coronavirus. Since its introduction <1 year ago, this virus has infected 8098 people in 26 countries, killing 774 of them. We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experience.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • China / epidemiology
  • Communicable Diseases, Emerging / diagnosis
  • Communicable Diseases, Emerging / drug therapy
  • Communicable Diseases, Emerging / epidemiology
  • Communicable Diseases, Emerging / physiopathology
  • Disease Outbreaks
  • Humans
  • Infection Control
  • Infectious Disease Transmission, Patient-to-Professional
  • Ribavirin / therapeutic use
  • SARS Virus*
  • Severe Acute Respiratory Syndrome* / diagnosis
  • Severe Acute Respiratory Syndrome* / drug therapy
  • Severe Acute Respiratory Syndrome* / epidemiology
  • Severe Acute Respiratory Syndrome* / physiopathology
  • World Health Organization

Substances

  • Antiviral Agents
  • Ribavirin